1394373-84-2

Upstream product

• 1394373-61-5 (3R,3aR,6R,6aR)-6-[5-(4-bromophenyl)-6-chloro-1-(2-trimethylsilylethoxymethyl)imidazo[4,5-b]pyridin-2-yl]oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol 
• 1394373-18-2 6-chloro-5-iodo-2-(methylsulfonyl)-1H-imidazo[4,5-b]pyridine 
• 1394373-25-1 6-chloro-5-iodo-1,3-dihydro-2H-imidazo [4,5-b] pyridine-2-thione 
• 1394373-23-9 5-chloro-6-iodopyridine-2,3-diamine 
• 1394373-21-7 5-chloro-6-iodo-3-nitropyridin-2-amine 
• 203794-33-6 2-amino-5,6-dichloro-3-nitropyridine 
• 5409-39-2 2-amino-5-chloro-3-nitropyridine 

Downstream Products

• 1394372-86-1 (3R,3aR,6R,6aR)-6-((6-chloro-5-(4-(piperidin-4-ylethynyl)phenyl)-1H-imidazo[4,5-b]pyridin-2-yl)oxy)hexahydrofuro[3,2-b]furan-3-ol 
• 1394371-78-8 (3R,3aR,6R,6aR)-6-[[6-chloro-5-[4-[4-(1-methylimidazol-2-yl)phenyl]phenyl]-1H-imidazo[4,5-b]pyridin-2-yl]oxy]-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol 

Relevant academic research and scientific papers

NOVEL AZABENZIMIDAZOLE HEXAHYDROFURO[E,2-B]FURAN DERIVATIVES

Novel compounds of the structural formula (I) are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases mediated by the AMPK activated protein kinase. The compounds of the present invention may be usef

NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS

Novel compounds of structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.